Literature DB >> 24035415

YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function.

Ryouhei Tsutsumi1, Mohammad Masoudi, Atsushi Takahashi, Yumiko Fujii, Takeru Hayashi, Ippei Kikuchi, Yumeko Satou, Masanori Taira, Masanori Hatakeyama.   

Abstract

SHP2 is a ubiquitously expressed protein tyrosine phosphatase, deregulation of which is associated with malignant neoplasms and developmental disorders. SHP2 is required for full activation of RAS-Erk signaling in the cytoplasm and is also present in the nucleus, where it promotes Wnt target gene activation through dephosphorylation of parafibromin. SHP2 is distributed both to the cytoplasm and nucleus at low cell density but is excluded from the nucleus at high cell density. Here, we show that SHP2 physically interacts with transcriptional coactivators YAP and TAZ, targets of the cell-density-sensing Hippo signal. Through the interaction, nonphosphorylated YAP/TAZ promote nuclear translocalization of SHP2, which in turn stimulates TCF/LEF- and TEAD-regulated genes via parafibromin dephosphorylation. Conversely, YAP/TAZ phosphorylated by Hippo signaling sequester SHP2 in the cytoplasm, thereby preventing nuclear accumulation of SHP2. Hence, YAP/TAZ serve as a rheostat for nuclear SHP2 function, which is switched off by the Hippo signal.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24035415     DOI: 10.1016/j.devcel.2013.08.013

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  37 in total

1.  The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.

Authors:  M Shanzer; I Ricardo-Lax; R Keshet; N Reuven; Y Shaul
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

2.  c-Abl antagonizes the YAP oncogenic function.

Authors:  R Keshet; J Adler; I Ricardo Lax; M Shanzer; Z Porat; N Reuven; Y Shaul
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

Review 3.  Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma.

Authors:  Taohui Ouyang; Wei Meng; Meihua Li; Tao Hong; Na Zhang
Journal:  Cell Mol Neurobiol       Date:  2019-11-25       Impact factor: 5.046

Review 4.  YAP and TAZ: a nexus for Hippo signaling and beyond.

Authors:  Carsten Gram Hansen; Toshiro Moroishi; Kun-Liang Guan
Journal:  Trends Cell Biol       Date:  2015-06-02       Impact factor: 20.808

5.  Snail/Slug-YAP/TAZ complexes cooperatively regulate mesenchymal stem cell function and bone formation.

Authors:  Yi Tang; Stephen J Weiss
Journal:  Cell Cycle       Date:  2017-01-23       Impact factor: 4.534

6.  Nuclear Shp2 directs normal embryo implantation via facilitating the ERα tyrosine phosphorylation by the Src kinase.

Authors:  Hao Ran; Shuangbo Kong; Shuang Zhang; Jianghong Cheng; Chan Zhou; Bo He; Qiliang Xin; John P Lydon; Francesco J DeMayo; Gen-Sheng Feng; Guoliang Xia; Zhongxian Lu; Chao Wang; Haibin Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-19       Impact factor: 11.205

Review 7.  The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.

Authors:  Manami Kodaka; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2014-09-30       Impact factor: 9.261

8.  The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma.

Authors:  EeeLN H Buckarma; Nathan W Werneburg; Caitlin B Conboy; Ayano Kabashima; Daniel R O'Brien; Chen Wang; Sumera Rizvi; Rory L Smoot
Journal:  Mol Cancer Res       Date:  2020-07-09       Impact factor: 5.852

Review 9.  Tyrosine phosphorylation of WW proteins.

Authors:  Nina Reuven; Matan Shanzer; Yosef Shaul
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-26

10.  Cytotoxic activity of Shp2 inhibitor fumosorinone in human cancer cells.

Authors:  Chuan Chen; Tongdan Xue; Peng Fan; Linlin Meng; Jingjing Wei; Duqiang Luo
Journal:  Oncol Lett       Date:  2018-04-27       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.